Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
MOORESTOWN, N.J., Nov. 01, 2016 -- Tabula Rasa HealthCare (NASDAQ:TRHC) announced today its Chairman and CEO Calvin H. Knowlton, PhD, has been named a finalist by SmartCEO magazine for its 2016 Circle of Excellence – Technology Award. The Award “recognizes the region’s most accomplished CEOs for business excellence”.
According to SmartCEO, companies are nominated from all size and industry categories, public and private. An independent committee of business leaders selects the winners based on “industry impact, innovation and market leadership”.
“Tabula Rasa HealthCare is devoted to leveraging technology to improve health care,” said Knowlton. “We are at the forefront of precision medicine with solutions that help clients tailor medical treatment to the individual characteristics of each patient. Our cloud-based software applications are designed to identify high-risk individuals, detect susceptibility to adverse drug events (ADEs) and embed proper dosing guidelines.”
TRHC products and services are built around the Company’s proprietary Medication Risk Mitigation Matrix® and other software applications that provide solutions for a range of payors, providers and healthcare organizations. TRHC is the market leader in providing medication risk management, risk adjustment and front-end coding for the Program of All-Inclusive Care for the Elderly (PACE), as well as a leader in pharmacy cost management solutions.
Finalists will be profiled in the November/December issue of SmartCEO magazine. The winners are celebrated at a gala event November 9, 2016 in Philadelphia.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, please visit: www.TRHC.com.
Contact: Media Dianne Semingson [email protected] T: 215-870-0829 Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 [email protected]
